Toward Progress in Quantitative Translational Medicine: A Call to Action
Overview
Authors
Affiliations
Quantitative translational medicine (QTM) is envisioned as a multifaceted discipline that will galvanize the path from idea to medicine through quantitative translation across the discovery, development, regulatory, and utilization spectrum. Here, we summarize results of an American Society for Clinical Pharmacology and Therapeutics (ASCPT) survey on barriers relevant to the advancement of QTM and propose opportunities for its deployment. Importantly, we offer a call to action to break down these barriers through patient-centered stewardship, effective communication, cross-sector collaboration, and a modernized educational curriculum.
Training the next generation of pharmacometric modelers: a multisector perspective.
Bonate P, Barrett J, Ait-Oudhia S, Brundage R, Corrigan B, Duffull S J Pharmacokinet Pharmacodyn. 2023; 51(1):5-31.
PMID: 37573528 DOI: 10.1007/s10928-023-09878-4.
Zheng S, Venkatakrishnan K, Kennedy B Clin Transl Sci. 2022; 15(10):2355-2365.
PMID: 35981318 PMC: 9579401. DOI: 10.1111/cts.13364.
Pharmacometrics meets statistics-A synergy for modern drug development.
Ryeznik Y, Sverdlov O, Svensson E, Montepiedra G, Hooker A, Wong W CPT Pharmacometrics Syst Pharmacol. 2021; 10(10):1134-1149.
PMID: 34318621 PMC: 8520751. DOI: 10.1002/psp4.12696.
Application of Machine Learning in Translational Medicine: Current Status and Future Opportunities.
Terranova N, Venkatakrishnan K, Benincosa L AAPS J. 2021; 23(4):74.
PMID: 34008139 PMC: 8130984. DOI: 10.1208/s12248-021-00593-x.
Achour B, Al-Majdoub Z, Grybos-Gajniak A, Lea K, Kilford P, Zhang M Clin Pharmacol Ther. 2020; 109(1):222-232.
PMID: 33141922 PMC: 7839483. DOI: 10.1002/cpt.2102.